InicioSTAR • NSE
add
Strides Pharma Science Ltd
Cierre anterior
1643,30 ₹
Intervalo diario
1593,55 ₹ - 1654,95 ₹
Intervalo anual
467,00 ₹ - 1675,00 ₹
Cap. bursátil
149,79 mil M INR
Volumen medio
349,47 mil
Relación precio-beneficio
3.343,12
Rentabilidad por dividendo
0,15 %
Bolsa de valores principal
NSE
Noticias sobre los mercados
Datos financieros
Estado de resultados
Ingresos
Ingresos netos
(INR) | jun 2024info | Cambio interanual |
---|---|---|
Ingresos | 10,88 mil M | 16,94 % |
Gastos operativos | 4986,72 M | 13,84 % |
Ingresos netos | 702,02 M | 1.086,95 % |
Margen de beneficio neto | 6,46 | 950,00 % |
Beneficios por acción | — | — |
EBITDA | 2235,58 M | 33,22 % |
Tipo impositivo efectivo | 19,80 % | — |
Balance general
Activos totales
Responsabilidades totales
(INR) | jun 2024info | Cambio interanual |
---|---|---|
Efectivo y a corto plazo | 2969,24 M | -19,05 % |
Activos totales | — | — |
Responsabilidades totales | — | — |
Patrimonio total | 20,72 mil M | — |
Acciones en circulación | 91,89 M | — |
Precio-valor contable | 7,10 | — |
Rentabilidad económica | — | — |
Retorno sobre capital | 9,17 % | — |
Flujo de caja
Variación neta del flujo de caja
(INR) | jun 2024info | Cambio interanual |
---|---|---|
Ingresos netos | 702,02 M | 1.086,95 % |
Efectivo de operaciones | — | — |
Efectivo de inversión | — | — |
Efectivo de financiación | — | — |
Variación neta del flujo de caja | — | — |
Flujo de caja libre | — | — |
Información sobre la empresa
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore in southern India. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. Its softgel manufacturing capability consists of an annual capacity of 50,000 machine hours or about three billion softgel capsules. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. In the United States and Canadian markets, the company partners with generic companies to supply retail and hospital generics in injectable products and softgels. In European markets, it has long-term relationships for the development of projects and supply agreements with the European companies. In Australia and New Zealand, the company is engaged in manufacturing and supply of soft gels and value-added manufacturing. The company has development and supply agreements with South African companies. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India. Wikipedia
Fundación
1990
Sitio web
Empleados
3.065